Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2964449)

Published in Prev Med on August 27, 2010

Authors

Saloua Akoudad1, Moyses Szklo, Mara A McAdams, Tibor Fulop, Cheryl A M Anderson, Josef Coresh, Anna Köttgen

Author Affiliations

1: Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA. 295523sa@student.eur.nl

Articles cited by this

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83

Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87

Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34

Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

The role of overweight and obesity in calcium oxalate stone formation. Obes Res (2004) 2.26

Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol (1996) 2.17

Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int (2005) 2.00

Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis (2008) 1.91

Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol (2006) 1.90

Body size and risk of kidney stones. J Am Soc Nephrol (1998) 1.78

Demographic and geographic variability of kidney stones in the United States. Kidney Int (1994) 1.75

Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet (2009) 1.73

Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol (1982) 1.70

Nephrolithiasis and risk of hypertension. Am J Hypertens (1998) 1.56

The natural history of calcium urolithiasis. JAMA (1977) 1.55

Essential arterial hypertension and stone disease. Kidney Int (1999) 1.49

Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens (2008) 1.40

Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis (1998) 1.38

Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol (2008) 1.36

Kidney stone disease and risk factors for coronary heart disease. Int J Urol (2005) 1.27

Kidney stones and hypertension: population based study of an independent clinical association. BMJ (1990) 1.26

Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol (1994) 1.21

Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis (2005) 1.12

Impact of dietary habits on stone incidence. Urol Res (2006) 1.01

Relationship among risk factors for nephrolithiasis, cardiovascular disease, and ethnicity: focus on a law enforcement cohort. AAOHN J (2004) 0.83

The role of biliary calcium in gallstone pathogenesis. Front Biosci (2002) 0.83

Incidence and natural history of renal stone disease and its relationship to calcium metabolism. Eur Urol (1978) 0.78

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42

MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98

Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51

Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Chronic kidney disease. Lancet (2011) 5.42

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74

Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med (2007) 4.58

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54

Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23

Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 4.00

Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96

Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis (2013) 3.82

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet (2009) 3.60

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48

Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol (2008) 3.44

Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol (2003) 3.40

Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2010) 3.37

Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A (2009) 3.13

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol (2010) 3.12

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2007) 3.08

Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol (2004) 3.00

Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol (2003) 2.95

The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) (2008) 2.93

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83

Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76

Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol (2005) 2.74